Neurophysiological effects of capsaicin

Lisa C. Russell, Kim Burchiel

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Data obtained from neonatally treated rats are fairly consistent. However, there is disagreement as to whether mechanical and thermal nociceptive thresholds are elevated or unchanged in this group. There are at least two major areas of disagreement in adult animal capsaicin research. Behavioral data are extremely variable. The thermal nociceptive threshold after systemic capsaicin has been reported to be both raised and lowered. After intrathecal capsaicin injection, the thermal nociceptive threshold was reported raised, but onset and duration of responses varied and some animals exhibited no changes. Capsaicin application to peripheral nerve, however, drastically increased thermal threshold. Mechanical pain threshold has been reported both increased and unchanged after systemic capsaicin treatment and unchanged after intrathecal injection. Obviously, capsaicin's effects upon pain perception are not fully understood. Although lower on the phylogenetic scale than many mammals, rodents exhibit complex individualistic behavior. Lower vertebrates may eventually provide more simple behavioral models for pain tolerance. Investigators also disagree as to whether C fibres can conduct action potentials after local capsaicin application. C fibre conduction was reported unaffected by capsaicin in an acute preparation and for 13-21 days after treatment. On the other hand, C fibre compound action potentials have been reported diminished for up to 2 h after capsaicin application. Additional conduction impairment studies will be useful in comparing peripheral and intrathecal capsaicin application. There is general agreement that, allowing for variation in dosages and route of administration, capsaicin causes central and peripheral C fibre damage, though never as extensive in adults as in neonates. Neonatal capsaicin treatment (always s.c.) results in destruction of C and some Aδ fibres and their central terminals. Capsaicin causes degeneration of C terminals in the adult CNS only when applied centrally. In both neonates and adults, s.c. capsaicin depletes the putative 'pain' peptide neurotransmitter, SP, from peripheral and sensory neurons and the tissues they innervate but not from the gut. Capsaicin-induced SP depletion in neonates is permanent. Systemic administration to adult depleted SP from much the same areas as observed in neonates, but all areas but the medulla exhibited a slow, regional recovery. Intraventricular injection of capsaicin depleted SP in the adult medulla only, while other SP-containing areas affected by systemic injection remained intact. Intranigral capsaicin injection had no effect on SP content but depleted 5-HT and its metabolite, 5-HIAA, and dopamine metabolites. Direct application of capsaicin to the sciatic nerve may block axonal peptide transport in sensory C fibres but not in motor fibres. In neonates, capsaicin depleted peptide markers of primary afferents, i.e., SRIF, VIP, CCK, FRAP, GABA and opiate receptors from the spinal cord and/or DRG. Systemic administration to adults depleted SRIF and FRAP in the dorsal spinal cord but not opiate receptors or glutamic acid decarboxylase (GAD) activity. Probably because of capsaicin-induced structural and biochemical alterations, spinal, medullary, and peripheral neurons become at least temporarily less responsive, although not uniformly so. Neonatal capsaicin treatment abolished the C fibre mediated neurogenic oedema response to injury or irritation. Subcutaneous administration or direct (but not intrathecal) application of capsaicin to peripheral nerve temporarily blocked neurogenic oedema in adults. On a gross scale, pharmacological tests employing capsaicin are aimed at identifying the receptors it affects to explain complex visceral reflex mechanisms. Neurophysiological tests are more specific because so far, capsaicin has been found to affect only nociceptive primary afferents. At the cellular level, capsaicin depolarizes sensory terminals and exerts a Ca2+ dependent SP release in the spinal cord. Capsaicin prolongs sensory neuron action potentials, whereas opiates and opioid peptides shorten AP duration and inhibit SP release from spinal sensory terminals. Capsaicin's hyperpolarization of DRG neurons provides an interesting contrast that indicates differences in its effects on ganglionic, axonal, terminal and receptor sites. Also due to its specific action, capsaicin has been used to indicate presynaptic opiate receptors on SP-releasing spinal nociceptive terminals.

Original languageEnglish (US)
Pages (from-to)165-176
Number of pages12
JournalBrain Research Reviews
Volume8
Issue number2-3
DOIs
StatePublished - 1984
Externally publishedYes

Fingerprint

Capsaicin
Unmyelinated Nerve Fibers
Opioid Receptors
Hot Temperature
Action Potentials
Spinal Injections
Spinal Cord
Opioid Peptides
Diagnosis-Related Groups
Sensory Receptor Cells
Peripheral Nerves
Peptides
Edema

Keywords

  • capsaicin - C-fibers - pain - substance P

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Neurophysiological effects of capsaicin. / Russell, Lisa C.; Burchiel, Kim.

In: Brain Research Reviews, Vol. 8, No. 2-3, 1984, p. 165-176.

Research output: Contribution to journalArticle

Russell, Lisa C. ; Burchiel, Kim. / Neurophysiological effects of capsaicin. In: Brain Research Reviews. 1984 ; Vol. 8, No. 2-3. pp. 165-176.
@article{49dd2499dcdb4bf79b58da0a32d6f4d7,
title = "Neurophysiological effects of capsaicin",
abstract = "Data obtained from neonatally treated rats are fairly consistent. However, there is disagreement as to whether mechanical and thermal nociceptive thresholds are elevated or unchanged in this group. There are at least two major areas of disagreement in adult animal capsaicin research. Behavioral data are extremely variable. The thermal nociceptive threshold after systemic capsaicin has been reported to be both raised and lowered. After intrathecal capsaicin injection, the thermal nociceptive threshold was reported raised, but onset and duration of responses varied and some animals exhibited no changes. Capsaicin application to peripheral nerve, however, drastically increased thermal threshold. Mechanical pain threshold has been reported both increased and unchanged after systemic capsaicin treatment and unchanged after intrathecal injection. Obviously, capsaicin's effects upon pain perception are not fully understood. Although lower on the phylogenetic scale than many mammals, rodents exhibit complex individualistic behavior. Lower vertebrates may eventually provide more simple behavioral models for pain tolerance. Investigators also disagree as to whether C fibres can conduct action potentials after local capsaicin application. C fibre conduction was reported unaffected by capsaicin in an acute preparation and for 13-21 days after treatment. On the other hand, C fibre compound action potentials have been reported diminished for up to 2 h after capsaicin application. Additional conduction impairment studies will be useful in comparing peripheral and intrathecal capsaicin application. There is general agreement that, allowing for variation in dosages and route of administration, capsaicin causes central and peripheral C fibre damage, though never as extensive in adults as in neonates. Neonatal capsaicin treatment (always s.c.) results in destruction of C and some Aδ fibres and their central terminals. Capsaicin causes degeneration of C terminals in the adult CNS only when applied centrally. In both neonates and adults, s.c. capsaicin depletes the putative 'pain' peptide neurotransmitter, SP, from peripheral and sensory neurons and the tissues they innervate but not from the gut. Capsaicin-induced SP depletion in neonates is permanent. Systemic administration to adult depleted SP from much the same areas as observed in neonates, but all areas but the medulla exhibited a slow, regional recovery. Intraventricular injection of capsaicin depleted SP in the adult medulla only, while other SP-containing areas affected by systemic injection remained intact. Intranigral capsaicin injection had no effect on SP content but depleted 5-HT and its metabolite, 5-HIAA, and dopamine metabolites. Direct application of capsaicin to the sciatic nerve may block axonal peptide transport in sensory C fibres but not in motor fibres. In neonates, capsaicin depleted peptide markers of primary afferents, i.e., SRIF, VIP, CCK, FRAP, GABA and opiate receptors from the spinal cord and/or DRG. Systemic administration to adults depleted SRIF and FRAP in the dorsal spinal cord but not opiate receptors or glutamic acid decarboxylase (GAD) activity. Probably because of capsaicin-induced structural and biochemical alterations, spinal, medullary, and peripheral neurons become at least temporarily less responsive, although not uniformly so. Neonatal capsaicin treatment abolished the C fibre mediated neurogenic oedema response to injury or irritation. Subcutaneous administration or direct (but not intrathecal) application of capsaicin to peripheral nerve temporarily blocked neurogenic oedema in adults. On a gross scale, pharmacological tests employing capsaicin are aimed at identifying the receptors it affects to explain complex visceral reflex mechanisms. Neurophysiological tests are more specific because so far, capsaicin has been found to affect only nociceptive primary afferents. At the cellular level, capsaicin depolarizes sensory terminals and exerts a Ca2+ dependent SP release in the spinal cord. Capsaicin prolongs sensory neuron action potentials, whereas opiates and opioid peptides shorten AP duration and inhibit SP release from spinal sensory terminals. Capsaicin's hyperpolarization of DRG neurons provides an interesting contrast that indicates differences in its effects on ganglionic, axonal, terminal and receptor sites. Also due to its specific action, capsaicin has been used to indicate presynaptic opiate receptors on SP-releasing spinal nociceptive terminals.",
keywords = "capsaicin - C-fibers - pain - substance P",
author = "Russell, {Lisa C.} and Kim Burchiel",
year = "1984",
doi = "10.1016/0165-0173(84)90005-5",
language = "English (US)",
volume = "8",
pages = "165--176",
journal = "Brain Research Reviews",
issn = "0165-0173",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Neurophysiological effects of capsaicin

AU - Russell, Lisa C.

AU - Burchiel, Kim

PY - 1984

Y1 - 1984

N2 - Data obtained from neonatally treated rats are fairly consistent. However, there is disagreement as to whether mechanical and thermal nociceptive thresholds are elevated or unchanged in this group. There are at least two major areas of disagreement in adult animal capsaicin research. Behavioral data are extremely variable. The thermal nociceptive threshold after systemic capsaicin has been reported to be both raised and lowered. After intrathecal capsaicin injection, the thermal nociceptive threshold was reported raised, but onset and duration of responses varied and some animals exhibited no changes. Capsaicin application to peripheral nerve, however, drastically increased thermal threshold. Mechanical pain threshold has been reported both increased and unchanged after systemic capsaicin treatment and unchanged after intrathecal injection. Obviously, capsaicin's effects upon pain perception are not fully understood. Although lower on the phylogenetic scale than many mammals, rodents exhibit complex individualistic behavior. Lower vertebrates may eventually provide more simple behavioral models for pain tolerance. Investigators also disagree as to whether C fibres can conduct action potentials after local capsaicin application. C fibre conduction was reported unaffected by capsaicin in an acute preparation and for 13-21 days after treatment. On the other hand, C fibre compound action potentials have been reported diminished for up to 2 h after capsaicin application. Additional conduction impairment studies will be useful in comparing peripheral and intrathecal capsaicin application. There is general agreement that, allowing for variation in dosages and route of administration, capsaicin causes central and peripheral C fibre damage, though never as extensive in adults as in neonates. Neonatal capsaicin treatment (always s.c.) results in destruction of C and some Aδ fibres and their central terminals. Capsaicin causes degeneration of C terminals in the adult CNS only when applied centrally. In both neonates and adults, s.c. capsaicin depletes the putative 'pain' peptide neurotransmitter, SP, from peripheral and sensory neurons and the tissues they innervate but not from the gut. Capsaicin-induced SP depletion in neonates is permanent. Systemic administration to adult depleted SP from much the same areas as observed in neonates, but all areas but the medulla exhibited a slow, regional recovery. Intraventricular injection of capsaicin depleted SP in the adult medulla only, while other SP-containing areas affected by systemic injection remained intact. Intranigral capsaicin injection had no effect on SP content but depleted 5-HT and its metabolite, 5-HIAA, and dopamine metabolites. Direct application of capsaicin to the sciatic nerve may block axonal peptide transport in sensory C fibres but not in motor fibres. In neonates, capsaicin depleted peptide markers of primary afferents, i.e., SRIF, VIP, CCK, FRAP, GABA and opiate receptors from the spinal cord and/or DRG. Systemic administration to adults depleted SRIF and FRAP in the dorsal spinal cord but not opiate receptors or glutamic acid decarboxylase (GAD) activity. Probably because of capsaicin-induced structural and biochemical alterations, spinal, medullary, and peripheral neurons become at least temporarily less responsive, although not uniformly so. Neonatal capsaicin treatment abolished the C fibre mediated neurogenic oedema response to injury or irritation. Subcutaneous administration or direct (but not intrathecal) application of capsaicin to peripheral nerve temporarily blocked neurogenic oedema in adults. On a gross scale, pharmacological tests employing capsaicin are aimed at identifying the receptors it affects to explain complex visceral reflex mechanisms. Neurophysiological tests are more specific because so far, capsaicin has been found to affect only nociceptive primary afferents. At the cellular level, capsaicin depolarizes sensory terminals and exerts a Ca2+ dependent SP release in the spinal cord. Capsaicin prolongs sensory neuron action potentials, whereas opiates and opioid peptides shorten AP duration and inhibit SP release from spinal sensory terminals. Capsaicin's hyperpolarization of DRG neurons provides an interesting contrast that indicates differences in its effects on ganglionic, axonal, terminal and receptor sites. Also due to its specific action, capsaicin has been used to indicate presynaptic opiate receptors on SP-releasing spinal nociceptive terminals.

AB - Data obtained from neonatally treated rats are fairly consistent. However, there is disagreement as to whether mechanical and thermal nociceptive thresholds are elevated or unchanged in this group. There are at least two major areas of disagreement in adult animal capsaicin research. Behavioral data are extremely variable. The thermal nociceptive threshold after systemic capsaicin has been reported to be both raised and lowered. After intrathecal capsaicin injection, the thermal nociceptive threshold was reported raised, but onset and duration of responses varied and some animals exhibited no changes. Capsaicin application to peripheral nerve, however, drastically increased thermal threshold. Mechanical pain threshold has been reported both increased and unchanged after systemic capsaicin treatment and unchanged after intrathecal injection. Obviously, capsaicin's effects upon pain perception are not fully understood. Although lower on the phylogenetic scale than many mammals, rodents exhibit complex individualistic behavior. Lower vertebrates may eventually provide more simple behavioral models for pain tolerance. Investigators also disagree as to whether C fibres can conduct action potentials after local capsaicin application. C fibre conduction was reported unaffected by capsaicin in an acute preparation and for 13-21 days after treatment. On the other hand, C fibre compound action potentials have been reported diminished for up to 2 h after capsaicin application. Additional conduction impairment studies will be useful in comparing peripheral and intrathecal capsaicin application. There is general agreement that, allowing for variation in dosages and route of administration, capsaicin causes central and peripheral C fibre damage, though never as extensive in adults as in neonates. Neonatal capsaicin treatment (always s.c.) results in destruction of C and some Aδ fibres and their central terminals. Capsaicin causes degeneration of C terminals in the adult CNS only when applied centrally. In both neonates and adults, s.c. capsaicin depletes the putative 'pain' peptide neurotransmitter, SP, from peripheral and sensory neurons and the tissues they innervate but not from the gut. Capsaicin-induced SP depletion in neonates is permanent. Systemic administration to adult depleted SP from much the same areas as observed in neonates, but all areas but the medulla exhibited a slow, regional recovery. Intraventricular injection of capsaicin depleted SP in the adult medulla only, while other SP-containing areas affected by systemic injection remained intact. Intranigral capsaicin injection had no effect on SP content but depleted 5-HT and its metabolite, 5-HIAA, and dopamine metabolites. Direct application of capsaicin to the sciatic nerve may block axonal peptide transport in sensory C fibres but not in motor fibres. In neonates, capsaicin depleted peptide markers of primary afferents, i.e., SRIF, VIP, CCK, FRAP, GABA and opiate receptors from the spinal cord and/or DRG. Systemic administration to adults depleted SRIF and FRAP in the dorsal spinal cord but not opiate receptors or glutamic acid decarboxylase (GAD) activity. Probably because of capsaicin-induced structural and biochemical alterations, spinal, medullary, and peripheral neurons become at least temporarily less responsive, although not uniformly so. Neonatal capsaicin treatment abolished the C fibre mediated neurogenic oedema response to injury or irritation. Subcutaneous administration or direct (but not intrathecal) application of capsaicin to peripheral nerve temporarily blocked neurogenic oedema in adults. On a gross scale, pharmacological tests employing capsaicin are aimed at identifying the receptors it affects to explain complex visceral reflex mechanisms. Neurophysiological tests are more specific because so far, capsaicin has been found to affect only nociceptive primary afferents. At the cellular level, capsaicin depolarizes sensory terminals and exerts a Ca2+ dependent SP release in the spinal cord. Capsaicin prolongs sensory neuron action potentials, whereas opiates and opioid peptides shorten AP duration and inhibit SP release from spinal sensory terminals. Capsaicin's hyperpolarization of DRG neurons provides an interesting contrast that indicates differences in its effects on ganglionic, axonal, terminal and receptor sites. Also due to its specific action, capsaicin has been used to indicate presynaptic opiate receptors on SP-releasing spinal nociceptive terminals.

KW - capsaicin - C-fibers - pain - substance P

UR - http://www.scopus.com/inward/record.url?scp=0021708519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021708519&partnerID=8YFLogxK

U2 - 10.1016/0165-0173(84)90005-5

DO - 10.1016/0165-0173(84)90005-5

M3 - Article

C2 - 6084533

AN - SCOPUS:0021708519

VL - 8

SP - 165

EP - 176

JO - Brain Research Reviews

JF - Brain Research Reviews

SN - 0165-0173

IS - 2-3

ER -